Atrial Activation Sensing for Hemodynamic Stability Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable medical devices (IMDs) cannot effectively discriminate between hemodynamically stable and unstable tachyarrhythmias, which is crucial for guiding therapy decisions.
Innovation Solution
A cardiac rhythm management device with an atrial activation sensing circuit, tachyarrhythmia detection circuit, and processor that compares atrial activation characteristics before and during tachyarrhythmia to determine hemodynamic stability, using atrial rate and variability to differentiate between stable and unstable tachyarrhythmias and adjust therapy accordingly.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If IMDs only detect tachyarrhythmia presence, then device complexity is reduced, but therapeutic decision-making capability is insufficient
Solution Approach 1:
The patent uses atrial activation characteristics as an intermediary parameter to indirectly assess hemodynamic stability during tachyarrhythmia. Instead of directly measuring complex hemodynamic parameters, the device monitors atrial activation rate and variability, which serve as mediators reflecting the underlying hemodynamic state. This allows the device to gain therapeutic decision-making capability while maintaining relatively simple device architecture.
2Ease of operation
If IMDs use simple tachyarrhythmia detection, then ease of operation is maintained, but therapy guidance capability is insufficient
Solution Approach 1:
The patent transforms the approach by changing from monitoring single parameters (like ventricular rate alone) to analyzing multiple parameters (atrial activation rate, atrial activation variability, and their changes over time). This parameter transformation enables precise discrimination of hemodynamic stability while maintaining ease of operation, as the device automatically processes these parameters through programmed algorithms.
3Measurement precision
If IMDs monitor multiple cardiac parameters, then measurement precision improves, but device complexity increases
Solution Approach 1:
The patent segments the monitoring function into distinct components: atrial activation sensing, tachyarrhythmia detection, and hemodynamic stability assessment. Each component processes specific aspects of cardiac activity independently, then integrates results to provide comprehensive characterization. This segmentation allows precise multi-parameter monitoring while managing device complexity through modular functional architecture.
Data Source
AI summary
Detected changes in atrial activation can be used to discriminate between hemodynamically stable and hemodynamically unstable tachyarrhythmias.